Omeros

(NASDAQ) OMER

Current Price$14.90

Market Cap$1.07B

Since IPO (2009)+71%

5 Year-17%

1 Year+108%

1 Month+37%

Omeros Financials at a Glance

Market Cap

$1.07B

Revenue (TTM)

$0.00

Net Income (TTM)

$3.35M

EPS (TTM)

$-0.50

P/E Ratio

-29.83

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$14.90

Volume

Open

$15.11

Price

$14.90

Volume

Open

$15.11

Previous Close

$14.90

Daily Range

$14.70 - $15.23

52-Week Range

$2.95 - $17.65

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$14.90

Volume

Open

$15.11

Previous Close

$14.90

Daily Range

$14.70 - $15.23

52-Week Range

$2.95 - $17.65

OMER News

Person checking medicine on a shelf in a pharmacy

Why Omeros Stock Skyrocketed Today

Eric VolkmanDec 24, 2025

individual-investor-looking-at-stock-charts-getty

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?

Cory RenauerOct 16, 2025

Page 1

OMER: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Omeros

Industry

Pharmaceuticals

Sector

Health Care

Employees

175

CEO

Gregory A. Demopulos, MD

Website

www.omeros.com

Headquarters

Seattle, WA 98119, US

OMER Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-50%

Return on Assets

-1%

Earnings Yield

-3.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.07B

Shares Outstanding

72.00M

Volume

Avg. Volume

1.05M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$122.80M

EBITDA

$121.83M

Operating Cash Flow

$116.09M

Capital Expenditure

$65.00K

Free Cash Flow

$116.16M

Cash & ST Invst.

$171.80M

Total Debt

$239.14M

Omeros Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.07B

N/A

Market Cap/Employee

$5.31M

N/A

Employees

202

N/A

Net Income

$86.45M

+375.7%

EBITDA

$28.85M

+12.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$67.34M

+42.4%

Accounts Receivable

$36.27M

-1.5%

Inventory

$0.00

N/A

Long Term Debt

$215.78M

+19.8%

Short Term Debt

$23.36M

-13.4%

Return on Assets

-1.03%

N/A

Return on Invested Capital

-49.60%

N/A

Free Cash Flow

$39.84M

-37.4%

Operating Cash Flow

$39.84M

-37.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

KALVKalVista Pharmaceuticals, Inc.

KALVKalVista Pharmaceuticals, Inc.$26.66+0.04%

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.60-1.84%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.85+2.78%

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$9.44+3.85%

ADCTADC Therapeutics S.A.

ADCTADC Therapeutics S.A.$3.68-3.92%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$2.31-5.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.51+0.01%

NOKNokia

NOKNokia$13.14-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

TSLATesla

TSLATesla$392.51+0.00%

Questions About OMER

What is the current price of Omeros?

Omeros is trading at $14.91 per share.

What is the 52-week range for Omeros?

Over the past 52 weeks, Omeros has traded between $2.95 and $17.65.

How much debt does Omeros have?

As of the most recent reporting period, Omeros reported total debt of $407.01M.

How much cash does Omeros have on hand?

Omeros reported $9.66M in cash and cash equivalents in its most recent financial results.

What is Omeros’s dividend yield?

Omeros does not currently have a dividend yield.

Omeros

Omeros Financials at a Glance

OMER News

Why Omeros Stock Skyrocketed Today

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?

Omeros Posts 2,652 Percent Sales Jump

Why Shares of Omeros Dropped on Monday

Why Omeros Stock Bolted Higher This Week

Why Omeros Corporation Stock Is Skyrocketing Today

Why Omeros Corporation Stock Is Marching Higher Today

Why Omeros Stock Is Freefalling Today

OMER: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Omeros

OMER Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Omeros Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OMER

What is the current price of Omeros?

What is the 52-week range for Omeros?

How much debt does Omeros have?

How much cash does Omeros have on hand?

What is Omeros’s dividend yield?

Premium Investing Services